Smart ring maker Oura has delayed its initial public offering on the Nasdaq, citing ongoing uncertainty in the public markets despite strong investor demand. The postponement comes just a week after the San Francisco-based company filed plans to raise up to $2.1 billion.
The health and fitness wearable company, founded in 2013, had drawn roughly four times as many orders as available shares during its preliminary marketing phase. Bankers working on the transaction had originally prepared to close the order books before the delay was announced in a company statement on Tuesday. The company had planned to list on the Nasdaq under the symbol OURA.
Market Conditions and the IPO Delay
Oura’s decision makes it the latest high-profile company to hit pause on a public listing amid volatile market sentiment. Other market hopefuls, including nuclear power services firm Holtec Nuclear Corp., have similarly withdrawn or delayed their debuts in recent weeks due to adverse conditions. Adverse market sentiment in equity markets prompted Holtec to pull its initial public offering earlier this month, with the company pointing out that data development uncertainty compounded existing hurdles—such as escalating energy costs, heightened global trade friction, persistent military conflicts, and growing fears of inflation—which have prompted central banks across the US, Japan, and the EU member states to elevate their benchmark interest rates. CVC Capital Partners-backed Bamboo Insurance Services Inc. also postponed its IPO within days of each other, citing market conditions.
Oura had formally launched its IPO plans just last week on Sept. 21, and the IPO was originally set to price Sept. 29 according to an investor presentation. Originally, the enterprise intended to secure as much as $2.2 billion by offering 50 million shares. In its filings with the US Securities and Exchange Commission, the company and selling shareholders offered 50 million shares for $40 to $44 each. The company was looking to sell 13.5 million shares, while shareholders including Forerunner Ventures and Lifeline Ventures were set to offer 36.5 million shares, bringing the secondary shares to approximately 73% of the offering.
At the top of the price range, the company would have had a market value of $14.1 billion based on the outstanding shares listed in its filings. Accounting for stock options and restricted share units, Oura would have had a fully diluted valuation of about $15 billion.
Goldman Sachs Group Inc., Morgan Stanley, JPMorgan Chase & Co., Allen & Co., and Jefferies Financial Group Inc. were leading the offering. BofA Securities, Barclays, Wells Fargo Securities, Citizens JMP, KeyBanc Capital Markets, Guggenheim Securities, Canaccord Genuity, Needham & Co., Raymond James, Rothschild, Truist Securities, and William Blair additionally participated as part of the broader group of joint bookrunners.
Financial Growth and User Base Expansion
Unlike many tech hopefuls entering public markets, Oura is profitable. The company reported that its revenue is expected to grow 90% year over year for the fiscal year 2026. The San Francisco, CA-based company booked $1.4 billion in revenue for the 12 months ended June 30, 2026.
Hardware, Subscriptions, and Biometric Data
Having debuted in 2015, the Oura smart ring has expanded far beyond simple sleep tracking to incorporate a diverse suite of wellness and health management tools. Over the past few years, the enterprise has increasingly prioritized the advancement of preventive medicine through analytics, artificial intelligence, novel functions, and additional features. More than 50 distinct biometric indicators—including heart rate, sleep cycles, stress levels, and body temperature—can be monitored by its rings, according to the company’s value proposition. Its sensor-laden rings have adorned the hands of celebrities including Lady Gaga and Coco Gauff.
The brand’s commercial traction stems from combining physical wearable devices with a digital subscription. Retail pricing for Oura’s rings spans from $350 to $500, supplemented by a $6 monthly membership fee that unlocks access to comprehensive data analytics and tailored health guidance. Between the middle of 2025 and the middle of 2026, Oura reports having shipped 3.6 million rings, successfully drawing in a large population of first-time buyers for whom the device serves as their inaugural wearable gadget.
Forrester analyst Arielle Trzcinski stated that Oura’s success is as much about the hardware aspect as it is about the subscription model and the revenue that comes from that, highlighting the fact that folks not only start wearing it and become paying members, but also that they wear it roughly five days a week, which is significant.
Because consumers increasingly favor health monitors that are screen-free, lightweight, and less obtrusive, overall demand for smart rings has expanded at a quicker pace than that of smartwatches. While Apple has dominated the smartwatch category, it doesn’t make a ring device, leaving Oura to outrun rivals in that space, including Samsung and Ultrahuman.
Worth a look